SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
Nereus is focusing on the oceans and marine environments as a source of small-molecule compounds for the treatment of inflammation, cancer, and infectious diseases. Nereus utilized specialized research out of the Scripps Institution of Oceanography.
Nereus
San Diego, CA
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.